制药巨头转向中国寻求新药,专利悬崖驱动数十亿美元交易

· cnbc.com

西方生物制药公司正日益转向中国寻找创新,以应对制药业所普遍恐惧的“专利悬崖”。

Novartis has signed a deal worth up to $7.8 billion, in the latest of a flurry of tie-ups between Big Pharma and Chinese biotechs. The Swiss pharma major is ent...


More AI market news · Market heatmap · StrategyVerse · Quant Research · WOBR.AI